Aquestive Therapeutics, Inc. (AQST) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$10,863
Total Return
8.62%
CAGR
1.67%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +3.50% |
| Median | -0.72% |
| Best | +127.24% |
| Worst | -57.26% |
| % of Windows Positive | 48.4% |
1-Year (252 Trading Days)
| Average | +49.92% |
| Median | +30.99% |
| Best | +740.01% |
| Worst | -85.98% |
| % of Windows Positive | 69.0% |
3-Year (756 Trading Days)
| Average | +189.85% |
| Median | +102.99% |
| Best | +705.95% |
| Worst | -45.50% |
| % of Windows Positive | 77.6% |
Risk Metrics
| Maximum Drawdown | -90.11% |
| Average Drawdown | -50.99% |
| Drawdown Duration | 970 Trading Days |
| Sortino Ratio | 0.67 |
| Calmar Ratio | 0.02 |
| CVaR (5%) | -10.30% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -37.62% (-67.34% ann.) | $3761.62 | $0.00 | $0.00 | $0.00 |
| 2025 | +81.46% | +$8146.05 | $0.00 | $0.00 | $0.00 |
| 2024 | +76.24% | +$7623.73 | $0.00 | $0.00 | $0.00 |
| 2023 | +123.95% | +$12394.88 | $0.00 | $0.00 | $0.00 |
| 2022 | -76.81% | $7681.25 | $0.00 | $0.00 | $0.00 |
| 2021 | -27.29% | $2728.95 | $0.00 | $0.00 | $0.00 |
| 2020 | -8.08% | $807.57 | $0.00 | $0.00 | $0.00 |
| 2019 | -7.62% | $761.89 | $0.00 | $0.00 | $0.00 |
| 2018 partial | -60.75% (-88.33% ann.) | $6074.77 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | July 25, 2018 – February 19, 2020 | -73.33% | -56.87% | $7333.33 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -58.41% | -100.00% | $5840.89 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +187.25% | +446.19% | +$18724.59 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +9.35% | +8.85% | +$935.26 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -84.68% | -86.35% | $8467.80 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +374.26% | +131.59% | +$37425.95 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -18.59% | -11.36% | $1858.59 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.